05/05/2023 HPV in 2023 Latest vaccine recommendations and research Watch our webinar recording for the latest updates on the human papillomavirus (HPV) vaccine, including an in-depth look at the use, effectiveness and safety of the vaccine. NCIRS webinar series Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Upcoming webinar – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Monkeypox vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The webinar covers: the HPV vaccine and its impact in Australia and globally a roadmap for cervical cancer elimination in Australia and our region changes to the Australian HPV vaccination schedule and their implications initiatives designed to maintain high levels of HPV vaccine coverage. Presentation recordings: HPV vaccine: where are we now? — Professor Julia Brotherton Professor Julia Brotherton Professor, Cancer Prevention Policy and Implementation – Melbourne School of Population and Global Health Professor Julia Brotherton is a public health physician, epidemiologist and Professor of Cancer Prevention Policy and Implementation at the Melbourne School of Population and Global Health at the University of Melbourne. She is also a Professorial Fellow at NCIRS. For over 15 years, Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination and cervical screening programs. She is a member of the WHO Director General’s Expert Advisory Group on Cervical Cancer Elimination and of the Coalition to Strengthen the HPV Immunization Community (CHIC) global HPV Vaccine Council, as well as a CI on both the National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) in Cervical Cancer Control and the NHMRC CRE in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians. Cervical cancer elimination modelling and work to support countries in the region — Dr Kate Simms Dr Kate Simms Senior Research Fellow – Daffodil Centre Dr Kate Simms leads the team on cervical cancer prevention in low and middle-income countries at the Daffodil Centre. Her research focuses on modelling the impact of HPV vaccination and cervical screening in these settings. She has been involved in modelled evaluations across a range of settings, including in Australia, New Zealand, England, the United States, Japan, China, Papua New Guinea and Malaysia, as well as for the WHO. Her modelling work has directly supported the renewal of the Australian National Cervical Screening Program, the WHO strategy for cervical cancer elimination and WHO’s updated cervical screening guidelines. Changes to the HPV vaccine schedule in Australia — Professor Michelle Giles (presented by Professor Kristine Macartney) Professor Michelle Giles Professor, Department of Obstetrics & Gynaecology – Monash University Professor Giles is an infectious diseases physician who specialises in infections in pregnancy and maternal immunisation. Her clinical research focus is on maternal immunisation and bloodborne viruses in pregnancy such as HIV, hepatitis B and hepatitis C. Michelle is co-lead of the Clinical and Health Systems Research cross-cutting discipline at the Doherty Institute. She holds clinical appointments at Alfred Health, The Royal Women’s Hospital, Monash Health and Western Health, as well as academic appointments at the Department of Infectious Diseases at the University of Melbourne and the Department of Obstetrics and Gynaecology at Monash University. During the COVID-19 pandemic, Michelle supported the government’s response through a focus on control of community transmission of infection and by leading policy advice for the COVID-19 vaccination program. Professor Kristine Macartney Director – NCIRS Kristine Macartney is a paediatrician, infectious disease specialist and vaccinologist. She previously worked in the US, at the Children’s Hospital of Philadelphia, and she was a founding member of the US Vaccine Education Center. Kristine’s particular interests include the translation of evidence into policy and practice; vaccine safety; and vaccine-preventable diseases research – particularly in viral diseases, including COVID-19, rotavirus, varicella zoster virus, human papillomavirus (HPV) and influenza. She is the senior editor of the Australian Immunisation Handbook, has authored more than 200 peer-reviewed publications and is a member of key peak advisory committees in Australia, including the Australian Technical Advisory Group on Immunisation (ATAGI). Kristine is also an expert consultant to the World Health Organization (WHO), a member of the WHO Global Advisory Committee on Vaccine Safety, a member of WHO-SAGE subcommittees and the Founding Chair of the Australian Regional Immunisation Alliance. She has a clinical appointment at The Children’s Hospital at Westmead as a Staff Specialist in Infectious Diseases and Microbiology and a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health at the University of Sydney. NSW Transition to a One Dose HPV Schedule — Sarah Hynes Sarah Hynes Senior Project Officer – Health Protection NSW Sarah is a Senior Project Officer in the Immunisation Branch of Health Protection NSW. She is an authorised immunisation nurse who oversees the NSW school vaccination program in the Ministry of Health. Her background is in public health throughout both NSW and Qld. Q&A session Dr Ketaki Sharma Staff Specialist, Immunisation – NCIRS Ketaki Sharma is a general paediatrician and staff specialist at NCIRS. She holds a conjoint appointment as Clinical Lecturer in the Discipline of Child and Adolescent Health at the University of Sydney. Ketaki is a member of the NCIRS team that provides scientific and technical support to ATAGI. She is also part of the New South Wales Immunisation Specialist Service. Ketaki is undertaking research on optimising vaccination during pregnancy to protect newborn infants from vaccine-preventable illnesses. She also has a special interest in vaccination of people with immunocompromise. Additional resources The Australian Immunisation Handbook - Australian Government Department of Health and Aged Care News & events All news & events 21 September 2023 | News Multiple vaccinations for children – new NCIRS resource 31 August 2023 | News PAEDS network provides crucial data on Strep A infections in Australia 10 July 2023 | News Immunisation for individuals with additional needs – Practical guide 20 June 2023 | News New Vaccination for Our Mob virtual report available now 3026 views